Stock Region Research
Subscribe
Sign in
Share this discussion
Leading Analyst Raises Price Targets For This Biotech Company
stockregion.app
Copy link
Facebook
Email
Note
Other
Leading Analyst Raises Price Targets For This…
Stock Region
Nov 20, 2023
Share this post
Leading Analyst Raises Price Targets For This Biotech Company
stockregion.app
Copy link
Facebook
Email
Note
Other
Cantor Fitzgerald Maintains Overweight on Taysha Gene Therapies, Raises Price Target to $7.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Leading Analyst Raises Price Targets For This Biotech Company
Leading Analyst Raises Price Targets For This…
Leading Analyst Raises Price Targets For This Biotech Company
Cantor Fitzgerald Maintains Overweight on Taysha Gene Therapies, Raises Price Target to $7.